What's on tap for your in-office drug billing next year? Find out about the new competitive acquisition program (CAP)

Why This Topic Matters

The article matters because it describes a proposed Medicare drug-supply model that could affect how physician offices obtain, document, and bill for Part B drugs. Practices that administer injectable or infusible drugs may need to assess whether the proposed program aligns with their workflow and payer environment.

Article Sections

1. CMS proposal for the competitive acquisition program

   Introduces the proposed Medicare Part B drug supply program and the general concept behind vendor participation and physician election.

2. Enrollment and election agreement details

   Summarizes the proposed physician enrollment process, annual participation framework, and related administrative requirements.

3. Operational requirements for claims and drug delivery

   Covers the article’s discussion of claims timing, documentation, vendor delivery issues, and circumstances involving alternate drug sources.

4. Physician and vendor concerns

   Describes questions raised by the physician community and concerns about vendor readiness, administration burden, and program logistics.

5. Considerations for practice participation

   Addresses the article’s broad discussion of how different practices may evaluate participation in the proposed program relative to existing drug payment arrangements.

6. Program timing and federal review

   Notes the proposed launch timeline and the request for federal approval of the physician election form.